References
- McDermott R, Rowley KG, Lee AJ, et al. Increase in prevalence of obesity and diabetes and decrease in plasma cholesterol in a central Australian Aboriginal community. Med J Aust 2000;172:480–4
- Ferriman D, Gallwey JD . Clinical assessment ofbody hair growth in women with hyperandrogenism. Endocrinol Metab 1961;21:1440–7
- Zawadzki JK, Dunaif A. Diagnostic criteria for polycystic ovary syndrome: towards a rational approach. In Dunaif A, Givens JR., Haseltine F, Merriam GR, eds. Polycystic Ovary Syndrome. Boston: Blackwell, 1992:377–84
- Legro RS, Finegood D, Dunaif A. A fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycystic ovary syn-drome. J Clin Endocrinol Metab 1998;83:2694–8
- Solomon CG. The epidemiology of p olycystic ovary syndrome. Prevalence and associated disease risk. Endocrinol Metab Clin North Am 1999;28:247–63
- Oberfield S. Metabolic lessons from the study of young adolescents with polycystic ovary syndrome — Is insulin, indeed the culprit? J Clin Endocrinol Metab 2000;85:3520–5
- Asuncion M, Calvo RI\4, San Milan JL, et al. A prospective study of the prevalence of the polycystic ovary syndrome in unselected caucasian women from Spain. J Clin Endocrinol Metab 2000;85: 2434–8
- Knochenhauer ES, Key TJ, Kashar-Miller M, et al. Prevalence of the polycystic ovary syndrome in unselected black and white women of the South-eastern United States: a prospective study. J Clin Endocrinol Metab 1998;83:3078–82
- Diamanti-Kandarakis E, Kouli CR, Bergiele AT, et al. A survey of the polycystic ovary syndrome in the greek island of Lesbos: hormonal and metabolic profile. J Clin Endocrinol Metab 1999;84:4006–11